RecruitingNCT00919217

Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms

Exploratory Study on the Timing of MS Symptoms

Sponsor

University of Louisville

Enrollment

80 participants

Start Date

Aug 1, 2008

Study Type

OBSERVATIONAL

Conditions

Relapsing Remitting Multiple Sclerosis

Summary

The investigators' overall hypothesis is that appearance or worsening of relapsing-remitting multiple sclerosis (RR-MS) symptoms are affected by various factors including stress, hormonal cycles, illness and missed medications.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Inclusion Criteria2

females
diagnosed with relapsing-remitting multiple sclerosis

Exclusion Criteria8

male
no diagnosis of relapsing-remitting MS
diagnosis of any other autoimmune disease or fibromyalgia
peri-, post-, or surgically menopausal
pregnant within past year or nursing
history of chemotherapy
on experimental medications
treatment with steroids in the last 30 days

Locations(1)

University of Louisville (recruiting nationwide)

Louisville, Kentucky, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00919217

Related Trials

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

NCT067965043 locations

RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.

NCT0575883123 locations

Functional Outcomes From Diets in Multiple Sclerosis

NCT053273222 locations

Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis

NCT059495805 locations

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

NCT0404762822 locations